Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGNT
2926
DELISTED
Cogentix Medical, Inc.
CGNT
| $324K | ﹤0.01% |
336,663
+17,500
| +5% | +$17.3K |
|
|
LUNA
2927
DELISTED
Luna Innovations Incorporated
LUNA
| $324K | ﹤0.01% |
261,005
+70,500
| +37% | +$77.4K |
|
|
OCRX
2928
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $321K | ﹤0.01% |
169,100
+22,700
| +16% | +$59.7K |
|
2929
Colony Bankcorp
CBAN
$460M
| $318K | ﹤0.01% |
33,400
+1,600
| +5% | +$15.2K |
|
2930
Gorman-Rupp
GRC
$2.13B
| $318K | ﹤0.01% |
11,600
+1,900
| +20% | +$52.9K |
|
|
JAX
2931
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $318K | ﹤0.01% |
+32,000
| New | +$326K |
|
|
SYUT
2932
DELISTED
Synutra International, Inc.
SYUT
| $317K | ﹤0.01% |
83,100
+4,100
| +5% | +$18.4K |
|
|
TISA
2933
DELISTED
TOP Image Systems Ltd
TISA
| $316K | ﹤0.01% |
164,648
-7,652
| -4% | -$12.8K |
|
|
UFS
2934
DELISTED
DOMTAR CORPORATION (New)
UFS
| $314K | ﹤0.01% |
9,000
-33,200
| -79% | -$1.28M |
|
|
CCXI
2935
DELISTED
ChemoCentryx, Inc.
CCXI
| $313K | ﹤0.01% |
69,681
-99,373
| -59% | -$373K |
|
2936
Clearway Energy Class C
CWEN
$5B
| $312K | ﹤0.01% |
+20,000
| New | +$305K |
|
2937
Urban One Class A
UONE
$22.7M
| $312K | ﹤0.01% |
9,960
+20
| +0.2% | +$455 |
|
2938
Fate Therapeutics
FATE
$283M
| $307K | ﹤0.01% |
180,700
-42,000
| -19% | -$76.1K |
|
2939
Home BancShares
HOMB
$6.21B
| $307K | ﹤0.01% |
15,500
-180,300
| -92% | -$3.78M |
|
|
ENFC
2940
DELISTED
Entegra Financial Corp.
ENFC
| $306K | ﹤0.01% |
17,500
+3,200
| +22% | +$56.1K |
|
|
ADYX
2941
DELISTED
Adynxx Inc
ADYX
| $304K | ﹤0.01% |
4,525
+2,228
| +97% | +$133K |
|
2942
AMREP Corp
AXR
$122M
| $303K | ﹤0.01% |
61,680
+1,400
| +2% | +$6.24K |
|
|
KAMN
2943
DELISTED
Kaman Corp
KAMN
| $303K | ﹤0.01% |
7,122
-77,278
| -92% | -$3.25M |
|
|
AEY
2944
DELISTED
ADDvantage Technologies Group
AEY
| $300K | ﹤0.01% |
16,970
+640
| +4% | +$11.5K |
|
|
ZGNX
2945
DELISTED
Zogenix, Inc.
ZGNX
| $299K | ﹤0.01% |
37,187
-36,900
| -50% | -$360K |
|
2946
ACNB Corp
ACNB
$654M
| $296K | ﹤0.01% |
+11,800
| New | +$274K |
|
2947
Matrix Service
MTRX
$347M
| $294K | ﹤0.01% |
17,800
-49,559
| -74% | -$836K |
|
|
SUMR
2948
DELISTED
Summer Infant, Inc.
SUMR
| $291K | ﹤0.01% |
19,500
+956
| +5% | +$13.4K |
|
|
SNMP
2949
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $289K | ﹤0.01% |
+880
| New | +$278K |
|
2950
Xenon Pharmaceuticals
XENE
$6.36B
| $286K | ﹤0.01% |
48,500
+14,700
| +43% | +$101K |
|
Similar funds
Renaissance Technologies's Q2 2016 Portfolio in Review
As of Q2 2016, Renaissance Technologies held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Renaissance Technologies withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Renaissance Technologies opened a new position in Nike worth $280M.
- Renaissance Technologies's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Renaissance Technologies added most to CVS Health in Q2 2016, an estimated $363M increase.
- Renaissance Technologies's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Renaissance Technologies fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Renaissance Technologies opened 423 new positions and closed 474 in Q2 2016.
- Renaissance Technologies's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.